Mr. Forrester has more than 25 years of life sciences experience and has held leadership roles in private and public pharmaceutical companies. He is a co-founder of IDRx, EQRx, Brixton Biosciences, Sesame Therapeutics and EyeCool Therapeutics.  He has served as the CXO of EQRx, CEO of Verastem Oncology, COO of Forma Therapeutics, CEO of CombinatoRx, and CFO of Coley Pharmaceutical. He also serves on the boards of AffyImmune Therapeutics, Anagenex, Deciduous Therapeutics , OnCusp Therapeutics and Pillar Biosciences. Robert also served as Managing Director of the Proprietary Investment Group at MeesPierson investing in life science companies. Prior to MeesPierson, Robert worked for the investment banks, Barclays Capital and UBS, in the corporate finance groups undertaking M&A, and public and private finance transactions. Robert started his career as lawyer with Clifford Chance in London, Singapore and Brunei. Robert has completed over $20 billion of transactions.  Mr. Forrester holds an LL.B. from Bristol University, UK.

Fun Fact:
Robert is on his third career and still trying to figure out what he is good at!  His passion is to change the world by making a difference for patients. And ice cream!